Evidence map›Paper›PMID 36410109›Full record

ReviewBiomaterials2022

Topography-mediated immunomodulation in osseointegration; Ally or Enemy.

Sajjad Shirazi, Sriram Ravindran, Lyndon F Cooper

Open access · greenAbstract readReview
In one paragraph

Review in Biomaterials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Research Progress on Biomaterials with Immunomodulatory Effects in Bone Regeneration.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Sajjad ShiraziDepartment of Oral Biology, College of Dentistry, University of Illinois Chicago, Chicago, IL, USA. Electronic address: s.shirazi.tbzmed88@gmail.com.
Sriram RavindranDepartment of Oral Biology, College of Dentistry, University of Illinois Chicago, Chicago, IL, USA.
Lyndon F CooperSchool of Dentistry, Virginia Commonwealth University, Richmond, VA, USA. Electronic address: cooperlf@vcu.edu.
Illinois College · USUniversity of Illinois Chicago · USVirginia Commonwealth University · US

Funding

3D Encapsulation, Bioprinting and Controlled Delivery of Functionally Engineered EVs (FEEs)R01DE030495 · NIDCR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI COOPER, LYNDON F, GAJENDRAREDDY, PRAVEEN · 2021 to 2025
$2.3M
Mesenchymal stem cell extracellular vesicles for ischemic retinal damageR01EY033902 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI STEVEN ROTH, Sriram Ravindran · 2022 to 2026
$2.1M
Functional Activation and Targeting of Exosomes for Regenerative MedicineR01DE027404 · NIDCR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GAJENDRAREDDY, PRAVEEN, RAVINDRAN, SRIRAM · 2018 to 2022
$2.1M
NEI NIH HHS R01 EY033902NIDCR NIH HHS R01 DE027404NIDCR NIH HHS R01 DE030495
6 · The paper itself

Abstract

Osteoimmunology is at full display during endosseous implant osseointegration. Bone formation, maintenance and resorption at the implant surface is a result of bidirectional and dynamic reciprocal communication between the bone and immune cells that extends beyond the well-defined osteoblast-osteoclast signaling. Implant surface topography informs adherent progenitor and immune cell function and their cross-talk to modulate the process of bone accrual. Integrating titanium surface engineering with the principles of immunology is utilized to harness the power of immune system to improve osseointegration in healthy and diseased microenvironments. This review summarizes current information regarding immune cell-titanium implant surface interactions and places these events in the context of surface-mediated immunomodulation and bone regeneration. A mechanistic approach is directed in demonstrating the central role of osteoimmunology in the process of osseointegration and exploring how regulation of immune cell function at the implant-bone interface may be used in future control of clinical therapies. The process of peri-implant bone loss is also informed by immunomodulation at the implant surface. How surface topography is exploited to prevent osteoclastogenesis is considered herein with respect to peri-implant inflammation, osteoclastic precursor-surface interactions, and the upstream/downstream effects of surface topography on immune and progenitor cell function.

Indexed as

OsseointegrationTitaniumImmunomodulationOsteogenesisSurface PropertiesTitaniumBMP-2ImmunoengineeringImplant surface topographyMacrophageNanoOncostatin MRoughness

Identifiers

PMID36410109
PMCPMC10148651
OpenAlexW4308566924

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.